Journal
AMERICAN JOURNAL OF GASTROENTEROLOGY
Volume 116, Issue 9, Pages 1954-1956Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.14309/ajg.0000000000001350
Keywords
-
Categories
Funding
- National Institute of Allergy and Infectious Diseases K23 award [1K23AI156132-01]
- National Institute of Child Health and Human Development [K23HD099240]
- National Institute of Diabetes and Digestive and Kidney Diseases K23 award [K23DK119585]
- National Institutes of Health/National Center for Advancing Translational Sciences Grant Support [UL1 TR000445]
Ask authors/readers for more resources
The impact of the 2019 US FDA safety alert and the COVID-19 pandemic on the use of FMT in children has led to changes in practices for many pediatric gastroenterologists, with a majority of programs being halted as a result.
INTRODUCTION: The impact of the 2019 US Food and Drug Administration safety alert involving transmission of multidrug resistant organisms through fecal microbiota transplantation (FMT), and the COVID-19 pandemic on the use of FMT in children, is unknown. METHODS: A survey of pediatric gastroenterologists performing FMT for Clostridioides difficile infection was conducted. RESULTS: Of 36 respondents, 17 (47%) and 30 (83%) changed their FMT practices related to the US Food and Drug Administration safety alert and COVID-19 pandemic, respectively, with 22 (61%) of programs halted. DISCUSSION: The US Food and Drug Administration safety alert and COVID-19 pandemic have substantially influenced the availability and access of FMT for children.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
